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Glycogen storage disease type Ia: Assessment and 
preanesthetic management - Case Report 
Anesthesia 
General Balanced Anesthesia  
Induction: Midazolam 1 mg + Fentanyl 100 µg + Propofol 100 mg   
Airway: laryngeal mask # 2,5 
Mantenaince: Sevoflurane in nitrous oxide/oxygen and air mixture 
Acetaminophen 500 mg iv 
Length of anesthesia : 55 minutes   
Per-operative period without accidents or complications. 
 
Time 9am 10am 11am 12am 13pm 
Glucose – venous blood 
(mg/dl) 
128 110 84 95 83 
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Hourly blood glucose monitoring  
Identification 
Boy, 11 years old, 29,6 Kg , ASA  III, with a diagnosis of G-Ia, since 12 
months old. 
Presented with hepatomegaly, growth retardation, elevated liver 
enzymes and hyperlipidemia.  
No previous surgeries and no history of allergies or atopy. 
Scheduled for elective circumcision. 
 
- At 6am: last meal of corn starch;  
- At 7am: admission and infusion of 5% glucose on half saline at a rate of 
75cc/h;  
- At 9am: hourly blood glucose determination was started ; 
- At 12h the surgery took place. 
Postoperative period 
At 2pm oral feeding resumed without any complications.  
Fig. 1 – Schema of glycogen metabolism 
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The pre-anesthetic evaluation and management of a patient with G-Ia is 
a challenge for the anesthesiologist, because these patients do not 
tolerate the fasting period required for the intervention (2). It is 
therefore necessary to adopt strategies to avoid hypoglycemia and 
lactic acidosis as well as its complications. According to the Pediatrics 
Department an adequate glycemic intake was selected, as well as its rate 
of administration; hourly blood glucose monitoring and infusion rate 
control were undertaken to maintain blood glucose levels above 60 mg/dl 
while avoiding acidosis. The use of Ringer´s lactate is not recommended 
by the risk of worsening lactic acidosis.  
Glycogen storage disease type Ia (G-Ia; von Gierke´s disease) is a rare 
inherited metabolic disorder resulting from glucose-6-phosphatase 
deficiency, a key enzyme in the glycogen metabolism (1).  Since patients 
are unable to release glucose from the liver, hypoglycemia and lactic 
acidosis after short periods of fasting, and hepatomegaly are the most 
common signs. Prevention of complications by maintenance of 
normoglycemia, demands the ingestion of corn starch in a 3 hourly basis.  
Hyperuricemia, hyperlipidemia and platelet dysfunction are also common 
(1).  
Pre-anesthetic evaluation  
